https://www.selleckchem.com/pr....oducts/marimastat.ht
68, 95% confidence intervals (CI) (1.51 to 1.87), p less then 0.00001, Fig.3a] and quality of life [RR = 1.51 95% CI (1.41 to 1.62), p less then 0.00001, Fig.4], and decreased the risk of treatment failure, myelosuppression, gastrointestinal reaction, and chest pain. For patients with moderate to large volume of the pleural effusion, primary treatment, KPS score ≥ 50-60, or anticipated survival time ≥ 3months, Lentinan (3-4 mg/time, once a week for three to four times) withcisplatin (30-40 mg/m2 or 50-60 mg/m2) significantly improved
Like
Comment
Share
